Navigation Links
Warner Chilcott Announces 2008 Financial Guidance
Date:1/28/2008

nted in the footnotes at the end of this press release.

For a full view of the Company's 2008 financial guidance please refer to the summary at the end of this press release.

Conference Call and Audio Webcast Today

Warner Chilcott will be hosting a conference call and audio webcast on January 28, 2008 at 8:30 a.m. EST to discuss the 2008 Financial Guidance for all interested parties. You may access the conference call by dialing (877) 874-1586 within the US and Canada, and (719) 325-4808 if you are outside the US and Canada. In addition, a live audio webcast of the call will be available at Warner Chilcott's Investor Relations website at http://ir.wcrx.com/events.cfm.

A replay of the conference call will be available for two weeks and can be accessed by dialing (888) 203-1112 from within the US or Canada and (719) 457-0820 if you are located outside the US or Canada. The pass code for the replay is 4419703. An archived version of the webcast will be available for two weeks on the Company's website at the same address noted above.

The Company

Warner Chilcott is a specialty pharmaceutical company focused on developing, manufacturing, marketing and selling branded prescription pharmaceutical products in women's healthcare and dermatology in the United States. WCRX-F

Forward Looking Statements

This press release contains forward-looking statements, including statements concerning the Company's operations, economic performance and financial condition, and business plans and growth strategy and product development efforts. These statements constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The words "may," "might," "will," "should," "estimate," "project," "plan," "anticipate," "expect," intend," "outlook," "believe" and other similar expressions are inten
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Warner Chilcott to Present at the 2008 Wachovia Healthcare Conference
2. Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference
3. Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007
4. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
5. Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco
6. WellPoint Announces Appearance at Upcoming Conference
7. OPKO Health Announces Changes to Board of Directors
8. NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results
9. IDEXX Laboratories Announces Fourth Quarter Results
10. U.S. Department of Labor Announces $1.25 Million to North Carolina to Help Trade-Affected Workers Pay for Health Insurance
11. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...w study shows that muscle cells grown in the lab c...properly. The work, performed in dogs and rats, mi... such as gastric reflux and fecal incontinence. ,...ers, which are the bands of muscle that separate t...ss in these areas can cause gastrointestinal esoph...
(Date:12/4/2009)...t men can be bastards and women must wear pearls a...nswer, according to an article in the Journal of ...xpressions. , In two studies, researchers asked ... In the first study, androgynous faces with lowere... more likely to be identified as male, and faces w...
(Date:12/4/2009)... federal regulators to crack down on abuse of opio...hDay News) -- The makers of 24 different prescript...tors with plans to curb the abuse of these opioid ...n under pressure from U.S. Food and Drug Administr... of fatal overdoses that occur with these medicati...
(Date:12/4/2009)... back during winter isn,t known, CDC says, , ...ber of states reporting widespread swine flu activ... high of 48 just two weeks ago, a U.S. health offi...N1 swine flu vaccine continues to increase, Dr. Th...Disease Control and Prevention, said during an aft...
(Date:12/4/2009)...lood vessel growth after heart attack , ,...lls appear to help repair heart attack damage, a n...nts found that stem cells from donor bone marrow p...issue damaged by heart attack. , The patients r... having a heart attack. During follow-up, they wer...
Breaking Medicine News(10 mins):Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Are angry women more like men? 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:Swine Flu Continues to Wane 2
...n gum bacteria, scientists had been able to use li...he oral cavity. The dental samples obtained f...were exposed to broadband light (380 to 520nm). Th... light had killed bacteria like Prevotella interme...
... titled Millennium Ecosystem Assessment, scientist...of the world are having a detrimental effect to hu...ears. Diseases such as malaria and cholera ar...ustainable way. The report emphasizes that th...
...at was published in American Journal of Public Hea...s possible to reduce the causes of asthma in child...searchers had identified 274 low-income households...ers used systematic interventions. Some of these i...
...udy conducted by US and Canadian scientists, consu...ked with having breast cancer for women. The...the incidence of breast cancer in 1461 cases, had ...imple carbohydrates and sugars like refined flour,...
...am that had looked into a data comprising of 5461 ...ss physical activity often makes these girls more ...at 16% of the participants take part in vigorous p...oing physical activity for fewer hours per week. T...
... market watchdog Food and Drug Administration had ... the drugs in the class of non-steroidal anti-infl...ription over the counter. These changes include th...rall risk associated with the drug overshadows the...
Other Medicine News:
(Date:12/4/2009)...4 Oxygen Biotherapeutics...that the first patient has been enrolled in the co...l in Switzerland for use of Oxycyte(TM) emulsion i...pany,s perfluorocarbon (PFC) therapeutic oxygen ca...ce in improving the outcome of patients with sever...
(Date:12/4/2009)...Dec. 4 Shared Imaging, LLC, an ind...d service programs for hospitals and healthcare pr...e Joint Commission,s Accreditation for Ambulatory ...gold seal of approval for quality and safety in pa...-wide for its mobile MRI and PET/CT services. Mobi...
(Date:12/4/2009)...NGTON, Dec. 4 Chemistr...shed by the Pharmaceutical Research and Manufactu...drugs and vaccines in development for HIV/AIDS and...hat the 97 products in development include 23 vacc...human clinical trials or awaiting approval by the ...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Mayo Clinic Executive Brent Phillips to Join Aurora Medical Group as Chief Operating Officer 58794 1Mayo Clinic Executive Brent Phillips to Join Aurora Medical Group as Chief Operating Officer 58794 2Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick Maryland 14340 1Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick Maryland 14340 2Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick Maryland 14340 3Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick Maryland 14340 4Personalized Medicine Killer Apps Will Transform Care Model 5199 1Personalized Medicine Killer Apps Will Transform Care Model 5199 2
...p Line Results of Phase II Study in Previous Nonre... Schering-Plough,Corporation (NYSE: SGP ) today ...gram for boceprevir, its investigational oral hepa...n ongoing Phase II study in,treatment-naive (previ...revir (800 mg TID) in combination with PEGINTRON(T...
...rmer HHS Secretary Tommy G. Thompson Addresses Exe... Exercise, WASHINGTON, Oct. 17 Representativ...organizations meet today with disaster,preparednes...itte), the,Nonprofit Roundtable of Greater Washing...tional Capital Area and The Center for Disability ...
Other Medicine Technology:Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 2Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 3Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 4Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 5Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 6Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 7Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 8Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 9Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region 2Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region 3Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region 4
Renu Rewetting Drops
Lens Plus Sterile Saline Solution
Softwear Saline
Sterile Preserved Saline Solution
Medicine Products: